SANTA CRUZ BIOTECHNOLOGY search Santa Cruz Biotechnology REL products
includes other brands or spellings
|
| emsa | | Santa Cruz Biotechnologies rabbit antibody against c-Rel was used in EMSA to study the regulation of human 3' Igh hs4 enhancer activity in B cells by synergistic interaction between Oct-2 and NF-kappaB. |
| emsa | | Santa Cruz Biotechnology anti-c-Rel antibody was used in EMSA to study the effect of mutated IκB kinase and IκBα on HAS1 activation. |
| ih | | Santa Cruz Biotech REL antibody was tested in immunohistochemistry by HPA (CAB004404) . |
| ih | | Santa Cruz Biotech cRel monoclonal antibody (MAb-sc-6955) was used in immunohistochemistry to study the expression pattern of NFκB family members in human melanocytic cells of normal skin, benign intradermal naevus and metastatic melanoma tissues. |
| wb | | Santa Cruz Biotechnology monoclonal anti-cRel antibody was used in Western blot to study the biological function of nerve growth factor in the regulation of dopamine D2 receptor expression. |
| wb | | Santa Cruz anti-c-Rel antibody was used in western blot to study the Rel family protein expression in splenic B cells of PKCß-/- (-/-) and PKCß+/+ (+/+) mice. |
Articles Reviewed |
| 1. Chiara Fiorentini et al. Nerve growth factor regulates dopamine D(2) receptor expression in prolactinoma cell lines via p75(NGFR)-mediated activation of nuclear factor-kappaB. 2002 |
| 2. Kaoru Saijo et al. Protein kinase C beta controls nuclear factor kappaB activation in B cells through selective regulation of the IkappaB kinase alpha. 2002 |
| 3. Manuel A Sepulveda et al. NF-kappa B and Oct-2 synergize to activate the human 3' Igh hs4 enhancer in B cells. 2004 |
| 4. Susan E McNulty et al. Comparative expression of NFkappaB proteins in melanocytes of normal skin vs. benign intradermal naevus and human metastatic melanoma biopsies. 2004 |
| 5. Karl M Stuhlmeier et al. Adenovirus-mediated gene transfer of mutated IkappaB kinase and IkappaBalpha reveal NF-kappaB-dependent as well as NF-kappaB-independent pathways of HAS1 activation. 2005 |
| 6. Anja Persson et al. A human protein atlas based on antibody proteomics. 2006 |